← FDA DRUG APPROVALS

FDA ANDA · ANDA087053

CHLORPROMAZINE HYDROCHLORIDE

Sponsor: WOCKHARDT

APPLICATION
ANDA087053
TYPE
ANDA
ORIGINAL APPROVAL
1981-02-04
LATEST ACTION
1990-11-16
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 100MG/ML · CONCENTRATE · ORAL

Approval history

1990-11-16Labeling · Supplement 15AP
1990-04-04Labeling · Supplement 14AP
1989-06-22Labeling · Supplement 12AP
1989-06-22Labeling · Supplement 13AP
1988-07-28Manufacturing (CMC) · Supplement 10AP
1988-07-28Manufacturing (CMC) · Supplement 9AP
1988-07-28Manufacturing (CMC) · Supplement 11AP
1987-05-18Manufacturing (CMC) · Supplement 6AP
1985-08-09Manufacturing (CMC) · Supplement 3AP
1981-02-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →